Melinta Therapeutics

Lincolnshire,  IL 
United States
  • Booth: 861

Melinta Therapeutics, Inc. (NASDAQ: MLNT) is a commercial-stage pharmaceutical company dedicated to meeting the continually evolving threat of bacterial infections by discovering, developing and commercializing a continual stream of novel antibiotics to provide new therapeutic options.


For Technical Support with this webpage, please contact support.